Early approval of Alnylam's gene-silencing drug in question

Alnylam Pharmaceuticals Inc said on Thursday it might have to hold off on plans to seek an accelerated approval for its gene-silencing drug, which showed effectiveness in a late-stage trial based on early data.

from Reuters: Health https://ift.tt/2N43fD6
via IFTTT

• Tweet
• Share
• Share
• Share
• Share